These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 18407764)

  • 1. The role of cis-regulatory elements in the design of gene therapy vectors for inherited blindness.
    Corbo JC
    Expert Opin Biol Ther; 2008 May; 8(5):599-608. PubMed ID: 18407764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness.
    Acland GM; Aguirre GD; Bennett J; Aleman TS; Cideciyan AV; Bennicelli J; Dejneka NS; Pearce-Kelling SE; Maguire AM; Palczewski K; Hauswirth WW; Jacobson SG
    Mol Ther; 2005 Dec; 12(6):1072-82. PubMed ID: 16226919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The consortium project to treat RPE65 deficiency in humans.
    Hauswirth WW
    Retina; 2005 Dec; 25(8 Suppl):S60. PubMed ID: 16374340
    [No Abstract]   [Full Text] [Related]  

  • 4. The cis-regulatory logic of the mammalian photoreceptor transcriptional network.
    Hsiau TH; Diaconu C; Myers CA; Lee J; Cepko CL; Corbo JC
    PLoS One; 2007 Jul; 2(7):e643. PubMed ID: 17653270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-specific cis-regulatory elements and mechanisms of non-coding genetic disease in human retina and retinal organoids.
    Thomas ED; Timms AE; Giles S; Harkins-Perry S; Lyu P; Hoang T; Qian J; Jackson VE; Bahlo M; Blackshaw S; Friedlander M; Eade K; Cherry TJ
    Dev Cell; 2022 Mar; 57(6):820-836.e6. PubMed ID: 35303433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial.
    Bennett J; Wellman J; Marshall KA; McCague S; Ashtari M; DiStefano-Pappas J; Elci OU; Chung DC; Sun J; Wright JF; Cross DR; Aravand P; Cyckowski LL; Bennicelli JL; Mingozzi F; Auricchio A; Pierce EA; Ruggiero J; Leroy BP; Simonelli F; High KA; Maguire AM
    Lancet; 2016 Aug; 388(10045):661-72. PubMed ID: 27375040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In utero gene therapy rescues vision in a murine model of congenital blindness.
    Dejneka NS; Surace EM; Aleman TS; Cideciyan AV; Lyubarsky A; Savchenko A; Redmond TM; Tang W; Wei Z; Rex TS; Glover E; Maguire AM; Pugh EN; Jacobson SG; Bennett J
    Mol Ther; 2004 Feb; 9(2):182-8. PubMed ID: 14759802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy for vision loss -- recent developments.
    Stieger K; Lorenz B
    Discov Med; 2010 Nov; 10(54):425-33. PubMed ID: 21122474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Massively parallel cis-regulatory analysis in the mammalian central nervous system.
    Shen SQ; Myers CA; Hughes AE; Byrne LC; Flannery JG; Corbo JC
    Genome Res; 2016 Feb; 26(2):238-55. PubMed ID: 26576614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De novo prediction of cis-regulatory elements and modules through integrative analysis of a large number of ChIP datasets.
    Niu M; Tabari ES; Su Z
    BMC Genomics; 2014 Dec; 15():1047. PubMed ID: 25442502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene therapy for retinal ganglion cell neuroprotection in glaucoma.
    Wilson AM; Di Polo A
    Gene Ther; 2012 Feb; 19(2):127-36. PubMed ID: 21975466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AAV-mediated gene therapy for retinal disorders in large animal models.
    Stieger K; Lhériteau E; Moullier P; Rolling F
    ILAR J; 2009; 50(2):206-24. PubMed ID: 19293463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant AAV-mediated gene transfer to the retina: gene therapy perspectives.
    Rolling F
    Gene Ther; 2004 Oct; 11 Suppl 1():S26-32. PubMed ID: 15454954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary results of gene therapy for retinal degeneration.
    Miller JW
    N Engl J Med; 2008 May; 358(21):2282-4. PubMed ID: 18441372
    [No Abstract]   [Full Text] [Related]  

  • 15. High-Throughput Analysis of Retinal Cis-Regulatory Networks by Massively Parallel Reporter Assays.
    Oh IY; Chen S
    Adv Exp Med Biol; 2019; 1185():359-364. PubMed ID: 31884638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy for Leber congenital amaurosis.
    Bennett J
    Novartis Found Symp; 2004; 255():195-202; discussion 202-7. PubMed ID: 14750605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety in nonhuman primates of ocular AAV2-RPE65, a candidate treatment for blindness in Leber congenital amaurosis.
    Jacobson SG; Boye SL; Aleman TS; Conlon TJ; Zeiss CJ; Roman AJ; Cideciyan AV; Schwartz SB; Komaromy AM; Doobrajh M; Cheung AY; Sumaroka A; Pearce-Kelling SE; Aguirre GD; Kaushal S; Maguire AM; Flotte TR; Hauswirth WW
    Hum Gene Ther; 2006 Aug; 17(8):845-58. PubMed ID: 16942444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological and rAAV gene therapy rescue of visual functions in a blind mouse model of Leber congenital amaurosis.
    Batten ML; Imanishi Y; Tu DC; Doan T; Zhu L; Pang J; Glushakova L; Moise AR; Baehr W; Van Gelder RN; Hauswirth WW; Rieke F; Palczewski K
    PLoS Med; 2005 Nov; 2(11):e333. PubMed ID: 16250670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adeno-associated virus mediated gene therapy for retinal degenerative diseases.
    Stieger K; Cronin T; Bennett J; Rolling F
    Methods Mol Biol; 2011; 807():179-218. PubMed ID: 22034031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Aedes aegypti cis-regulatory elements that promote gene expression in olfactory receptor neurons of distantly related dipteran insects.
    Mysore K; Li P; Duman-Scheel M
    Parasit Vectors; 2018 Jul; 11(1):406. PubMed ID: 29996889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.